Status:
COMPLETED
Plasma Pharmacokinetics of Alkylresorcinol Metabolites; New Candidate Biomarkers for Whole Grain Rye and Wheat Intake
Lead Sponsor:
University of Helsinki
Collaborating Sponsors:
Samfundet Folkhälsan
Sigrid Jusélius Foundation
Conditions:
Kinetics of Alkylresorcinol Metabolites
Eligibility:
All Genders
20-65 years
Brief Summary
The purpose of this study is to investigate the kinetics of two known alkylresorcinol metabolites in human subjects after intake of high-fiber rye bread. Whole grain rye is the most abundant source of...
Eligibility Criteria
Inclusion
- Healthy, volunteer
Exclusion
- Hemoglobin below 125 mmol/L in females and below 135 mmol/L in males use of antibiotics within 3 months before entering the study
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00953836
Start Date
March 1 2009
End Date
May 1 2009
Last Update
August 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Folkhälsan Research Center
Helsinki, Finland, 00250